4DMedical Ltd
4DMedical Limited is a medical technology company that creates and deploys software-based cardiothoracic imaging technology integrating both algorithms and artificial intelligence.
The business
4DMedical Limited is a medical technology company that creates and deploys software-based cardiothoracic imaging technology integrating both algorithms and artificial intelligence. The Company's software platform delivers quantitative insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease. It provides thoracic imaging that enhances physician diagnoses and management of respiratory conditions. Its products include CT:VQ-Non-Contrast Ventilation-Perfusion, CAC-Coronary Artery Calcification, CT LVAS-Lung Ventilation Analysis, IQ-UIP-Early IPF Detection, LDAf-Functional Lung Density Analysis, LDAi-Lung Density Analysis – Inspiration, LTA-Lung Texture Analysis, PHA-Pulmonary Hypertension Assessment, XV LVAS-Lung Ventilation Analysis, and Companion Imaging. The CT:VQ is a non-contrast post-processing technology that transforms routine, chest computed tomographies (CTs) into quantitative, lobar ventilation (V) and perfusion (Q) maps.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news

Softer resources drag down ASX 200 for the week
ASX 200 slips 0.5% as resources weaken, led by BHP and gold miners; Rio Tinto drops, NST sinks, oil rally fuels inflation fears.

Pulmonary imaging takes a leap as UC San Diego Health adopts 4DMedical CT:VQ
4D Medical (ASX: 4DX) inks UC San Diego Health as its 4th US centre to use CT:VQ, with launch pricing ahead of broader commercial rollout.

4DMedical Secures CT:VQ Imaging Commitment Through Expanded Philips Distribution Deal
4DMedical (ASX: 4DX) has secured a minimum US$10 million (A$15m) order commitment for its FDA-approved CT:VQ imaging solution under an expanded distribution agreement with multinational giant Philips.

4DMedical Extends Imaging Technology into Public Hospitals and National Screening Network
4DMedical (ASX: 4DX) has secured three significant agreements to expand the reach of its lung health imaging technology. In Australia, 4DMedical has locked in a multi-year deal with Spectrum Medical Imaging to support the National Lung Cancer Screening Program. The company will also launch a Brazilian lung screening program with a leading pharmaceutical partner, while […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.